Regenerative Meds: Indian Drug Makers Inject New Life Through Investments In Stem Cells
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Leading Indian companies are gearing up for emerging frontiers in medicine research, and among all the segments, regenerative therapies seem to be driving more and more initial investments from mainstream pharma companies